These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9290601)

  • 1. The metabolic crisis: a diagnostic challenge [editoria; comment].
    Bove KE
    J Pediatr; 1997 Aug; 131(2):181-2. PubMed ID: 9290601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic crisis in an infant--is the problem in the mitochondria?].
    Tyni T; Pihko H
    Duodecim; 2002; 118(13):1331-9. PubMed ID: 12239878
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden infant death syndrome and multiple acyl-coenzyme A dehydrogenase deficiency, ethylmalonic-adipic aciduria, or systemic carnitine deficiency.
    Harpey JP; Charpentier C; Coudé M; Divry P; Paturneau-Jouas M
    J Pediatr; 1987 Jun; 110(6):881-4. PubMed ID: 3585604
    [No Abstract]   [Full Text] [Related]  

  • 4. Medium chain acyl-coenzyme A dehydrogenase deficiency.
    Bennett MJ; Hale DE
    N J Med; 1992 Sep; 89(9):675-8. PubMed ID: 1436730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carnitine deficiency in inborn errors of metabolism].
    Sela BA; Lerman-Sagie T; Berkovitz M
    Harefuah; 1997 Nov; 133(10):419-23, 504. PubMed ID: 9418309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of orally ingested 3-phenylpropionic acid.
    Duran M; van Vossen R; Bruinvis L; Ketting D; Dorland L; de Klerk JB
    Prog Clin Biol Res; 1990; 321():419-26. PubMed ID: 2326303
    [No Abstract]   [Full Text] [Related]  

  • 7. Medium chain acyl coenzyme A dehydrogenase (MCAD) deficiency: the case for screening all newborns.
    Alluri VN; Mulvihill JJ
    J Okla State Med Assoc; 2002 May; 95(5):326-8. PubMed ID: 12043106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCAD deficiency. Acylcarnitines (AC) by tandem mass spectrometry (MS-MS) are useful to monitor dietary treatment.
    Abdenur JE; Chamoles NA; Specola N; Schenone AB; Jorge L; Guinle A; Bernard CI; Levandowskiy V; Lavorgna S
    Adv Exp Med Biol; 1999; 466():353-63. PubMed ID: 10709663
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicine. Fast technology drives new world of newborn screening.
    Marshall E
    Science; 2001 Dec; 294(5550):2272-4. PubMed ID: 11743177
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-mortem recognition of inherited metabolic disorders from specific acylcarnitines in tissue in cases of sudden infant death.
    Roe CR; Millington DS; Maltby DA; Wellman RB
    Lancet; 1987 Feb; 1(8531):512. PubMed ID: 2881073
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic tests for acyl-coenzyme A dehydrogenase deficiency.
    Elpeleg ON
    J Pediatr; 1992 Oct; 121(4):667-8. PubMed ID: 1403411
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medium chain Acyl-Coa Dehydrogenase deficiency. A diagnostic challenge for clinicians and laboratory].
    Heinonen OJ; Iitiä A; Irjala K; Pulkki K
    Duodecim; 1996; 112(1):35-41. PubMed ID: 10590599
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal screening for inborn errors of metabolism.
    Morris AA
    Indian Pediatr; 2000 Dec; 37(12):1303-6. PubMed ID: 11119331
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders].
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Zhang YJ; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):692-5. PubMed ID: 18067086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic defect in carnitine transport causing primary carnitine deficiency.
    Stanley CA; Treem WR; Hale DE; Coates PM
    Prog Clin Biol Res; 1990; 321():457-64. PubMed ID: 2326306
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany).
    Sander S; Janzen N; Janetzky B; Scholl S; Steuerwald U; Schäfer J; Sander J
    Eur J Pediatr; 2001 May; 160(5):318-9. PubMed ID: 11388605
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry.
    Leonard JV; Dezateux C
    BMJ; 2002 Jan; 324(7328):4-5. PubMed ID: 11777783
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurological diseases in disorders of organic acids.
    Marsden DL; Nyhan WL
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):349-54. PubMed ID: 1623263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders.
    Millington DS; Terada N; Chace DH; Chen YT; Ding JH; Kodo N; Roe CR
    Prog Clin Biol Res; 1992; 375():339-54. PubMed ID: 1438380
    [No Abstract]   [Full Text] [Related]  

  • 20. Public health explores expanding newborn screening for cystic fibrosis, congenital adrenal hyperplasia, and medium-chain acyl coenzyme A dehydrogenase deficiency (MCAD).
    Rhoades E; King P
    J Okla State Med Assoc; 2001 Apr; 94(4):129-32. PubMed ID: 11392180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.